Practical implementation of faecal transplantation

Clinical Microbiology and Infection

Volumn 20, Issue 11, 2014, Pages 1098-1105

  Kapel, N ^a   Thomas, M ^b   Corcos, O ^c   Mayeur, C ^b   Barbot Trystram, L ^a   Bouhnik, Y ^c   Joly, F ^c,d  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b UMR1319 MICALIS   (France)

^c BEAUJON HOSPITAL   (France)

^d CENTRE DE RECHERCHE SUR L INFLAMMATION   (France)

Author keywords

Clostridium difficile; Donor faeces infusion; Faecal transplantation; Microbiota; Recurrent infection

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL TOXIN; ENEMA; LAXATIVE;

BACTERIAL LOAD; BIOLOGICAL THERAPY; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; CLOSTRIDIUM DIFFICILE INFECTION; COLONOSCOPY; DONOR SELECTION; FECAL MICROBIOTA TRANSPLANTATION; FECES ANALYSIS; GOVERNMENT REGULATION; HUMAN; INTESTINE PREPARATION; MICROORGANISM DETECTION; NASOGASTRIC TUBE; PATIENT MONITORING; PRIORITY JOURNAL; RECIPIENT; REVIEW; RISK; SCREENING; STANDARDIZATION; TISSUE PREPARATION; TREATMENT OUTCOME; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; DIARRHEA; FECES; ISOLATION AND PURIFICATION; MICROBIOLOGY; PEPTOCLOSTRIDIUM DIFFICILE; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC);

CLOSTRIDIUM DIFFICILE;

BIOLOGICAL THERAPY; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; DIARRHEA; FECES; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84916884146     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12796     Document Type: Review

References (29)

1. Bakken JS, Borody T, Brandt LJ et al. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol 2011; 9: 1044-1049.
2. Kassam Z, Lee CH, Yuan Y, Hunt RH. Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol 2013; 108: 500-508.
3. Van Nood E, Vrieze A, Nieuwdorp M et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013; 368: 407-415.
4. Fuentes S, van Nood E, Tims S et al. Reset of a critically disturbed microbial ecosystem: faecal transplant in recurrent Clostridium difficile infection. ISME J 2014; 8: 1621-1633.
5. Debast SB, Bauer MP, Kuijper EJ, on behalf of the Committee. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect 2014; 20(suppl 2): 1-26.
6. Vrieze A, de Groot PF, Kootte RS, Knaapen M, van Nood E, Nieuwdorp M. Fecal transplant: a safe and sustainable clinical therapy for restoring intestinal microbial balance in human disease? Best Pract Res Clin Gastroenterol 2013; 27: 127-137.
7. Singh R, van Nood E, Nieuwdorp M et al. Donor feces infusion for eradication of extended spectrum beta-lactamase producing Escherichia coli in a patient with end stage renal disease. Clin Microbiol Infect 2014; doi: 10.1111/1469-0691.12683
8. FDA. Guidance for industry-Enforcement policy regarding investigational new drug requirements for use of fecal micro-biota for transplantation to treat Clostridium difficile infection not responsive to standard therapies (February 2014 Guidance for c onsultation). Center for Biologics Evaluation and Research, FDA doc. 79 FR 10814.
9. NICE. Interventional procedure overview of faecal microbiotatransplant for recurrent Clostridium difficile infection. IP 1096[IPG 485] (2013).
10. ANSM (Comité scientifique temporaire sur la transplantation de microbiote fécal). La transplantation de microbiote fécal et son encadrement dans les essais cliniques, 2014.
11. Smith MB, Coleen K, Alm EJ. Policy: how to regulate faecal transplants. Nature 2014; 506: 290-291.
12. Megerlin F, Lopert T, Taymor K, Trouvin JH. Biosimilars and the European experience: implications for the United States. Health Aff 2013; 10: 1803-1810.
13. Megerlin F, Fouassier E, Lopert R, Bourlioux P. Faecal microbiota transplantation: a sui generis biological drug, not a tissue. Ann Pharm Fr 2014; 72: 217-220
14. Kassam Z, Hundal R, Marshall JK, Lee CH. Fecal transplant via retention enema for refractory or recurrent Clostridium difficile infection. Arch Intern Med 2012; 172: 191-193.
15. Younster I, Sauk J, Pindar C et al. Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study. Clin Infect Dis 2014; 58: 1515-1522.
16. Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis 2011; 53: 994-1002.
17. Orenstein R, Griesbach CL, DiBaise JK. Moving fecal microbiota transplantation into the mainstream. Nutr Clin Pract 2013; 28: 589-598.
18. van Nood E, Speelman P, Nieuwdorp M, Keller J. Fecal microbiota transplantation: facts and controversies. Curr Opin Gastroenterol 2014; 30: 34-39.
19. Brandt LJ. American Journal of Gastroenterology Lecture: intestinal microbiota and the role of fecal microbiota transplant (FMT) in treatment of Clostridium difficile infection. Am J Gastroenterol 2013; 108: 177-185.
20. Tibble JA, Sigthorsson G, Foster R, Forgacs I, Bjarnason I. Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease. Gastroenterology 2002; 123: 450-460.
21. Hamilton MJ, Weingarden AR, Sadowsky MJ, Khoruts A. Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol 2012; 107: 761-767.
22. Weissman JS, Coyle W. Stool transplants: ready for prime time? Curr Gastroenterol Rep 2012; 14: 313-316.
23. Guo B, Harstall C, Louie T, Veldhuyzen van Zanten S, Dieleman LA. Systematic review: faecal transplantation for the treatment of Clostridium difficile-associated disease. Aliment Pharmacol Ther 2012; 35: 865-875.
24. Owens C, Broussard E, Surawicz C. Fecal microbiota transplantation and donor standardization. Trends Microbiol 2013; 21: 443-445.
25. Dodin M, Katz DE. Faecal microbiota transplantation for Clostridium difficile infection. Int J Clin Pract 2014; 68: 363-368.
26. Gustafsson A, Berstad A, Lund-Tønnesen S, Midtvedt T, Norin E. The effect of faecal enema on five microflora-associated characteristics in patients with antibiotic-associated diarrhoea. Scand J Gastroenterol 1999; 34: 580-586.
27. Garborg KI, Waagsbø B, Stallemo A, Matre J, Sundøy A. Results of faecal donor instillation therapy for recurrent Clostridium difficile-associated diarrhoea. Scand J Infect Dis 2010; 42: 857-861.
28. Surawicz CM, Brandt LJ, Binion DG et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol 2013; 108: 478-479.
29. Cohen SH, Gerding DN, Johnson S et al., Society for Healthcare Epidemiology of America; Infectious Diseases Society of America. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010; 31: 431-455.